My ePortfolio Register   

AACR 2017 /
Mutations in cancer predisposition genes and risk for subsequent neoplasms

1st - 5th Apr 2017

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 11.04.17
Views: 820

Dr Leslie Robison - St. Jude Children's Research Hospital, Memphis, USA

Dr Robison speaks with ecancer at AACR 2017 about genomic factors behind the life-long risks to cancer survivors.

From a patient cohort of over 4500 patients treated across 55 years, he describes how sequencing data from the first 3000 patients has revealed mutations in 156 predisposition genes linked to secondary lesions.

Dr Robison notes the logistics required in tracking down former patients, and the limitations of data gathering when former patients have since died, possibly because of a second cancer.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence